Hythiam Inc., through its Catasys subsidiary, provides specialized behavioral health management services to health plans, employers and unions through a network of licensed and company-managed health care providers. However, Hythiam does not practice medicine or manufacture, distribute or sell any sort of medications.

The company’s Catasys substance dependence program was designed to address substance dependence as a chronic disease. The program seeks to lower costs and improve member health through the delivery of integrated medical and psychosocial interventions in combination with long-term care coaching, including their proprietary treatment program for alcoholism and stimulant dependence.

Hythiam announced today that financial executive Peter Donato has joined the company as its chief financial officer. Mr. Donato brings nearly 20 years of professional experience to the company. Prior to joining Hythiam, he was chief financial officer at IRIS International, a publicly traded medical diagnostics company. Before his time at IRIS, Mr. Donato was also the chief financial officer at a medical imaging company.

Over Mr. Donato’s career, which includes stints at Ernst & Young, Accellent, Scotts-Miracle Gro, Honda and General Motors, he had a wide range of duties and experience. Mr. Donato has been responsible for rebuilding and managing finance and accounting departments, managing all aspects of SEC reporting and Sarbanes-Oxley compliance, running IT departments, and performing complex financial analysis to enhance operational efficiency and improve revenue and cost savings.

The COO of Hythiam, Rick Anderson, said, “His addition will allow us to better manage the increasing operational demands from current contracts and additional anticipated future contacts.” For more information on Hythiam, please visit its website at www.hythiam.com.